Physician profile
Collette Fox
NPI 1578842332
$3,563.07
in general payments reported to CMS, 2019-2025
13 companies · $255 in 2025
The $255 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,082 · 2022: $924 · 2023: $743 · 2024: $559 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,557.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $907.39 | 2021-2025 | Fasenra, Breztri, Tezspire |
| Novo Nordisk INC | $703.37 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $398.21 | 2021-2024 | |
| Glaxosmithkline, LLC. | $380.92 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Janssen Pharmaceuticals, INC | $319.25 | 2021-2022 | |
| Amgen INC. | $237.88 | 2021-2023 | Tezspire |
| Biohaven Pharmaceuticals, INC. | $175.46 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $134.56 | 2022 | |
| Dexcom, INC. | $130.33 | 2022-2024 | Dexcom G7 Gss (161) |
| Exact Sciences Corporation | $98.17 | 2025 | Cologuard Collection Kit |
| Pfizer INC. | $36.05 | 2022-2024 | |
| Boston Scientific Corporation | $25.98 | 2025 | Wavewriter Alpha Prime 16 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Collette Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.